Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 06, 2024
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease.
Journal: Allergy and asthma proceedings
Published: July 12, 2022
Dose Adjustment After Gaps in Administration of Subcutaneous Immunotherapy From a Past Survey: Work Group Report of the AAAAI Allergen Standardization and Allergy Diagnostics Committee.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 07, 2022
New insights in mite immunotherapy - sublingual tablets.
Journal: Current opinion in allergy and clinical immunology
Published: September 08, 2021
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 30, 2020
Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 28, 2020
Placebo effects in allergen immunotherapy-An EAACI Task Force Position Paper.
Journal: Allergy
Published: March 11, 2020
Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs.
Journal: Clinical and translational allergy
Published: February 28, 2020
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial.
Journal: The Journal of allergy and clinical immunology
Published: December 30, 2019
Acute emotional stress proposed as a risk factor for anaphylaxis in patients receiving allergen immunotherapy.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: October 24, 2019
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop.
Journal: The Journal of allergy and clinical immunology
Published: October 25, 2018
Last Updated: 09/26/2026